ICAP M&E M ASTER S LIDE D ECK D ATA THROUGH S EPTEMBER 30, 2011 Notes: Zambia is not included in this dataset.

2 C ONTENTS Site CensusSite Census Slide 3 Care and Treatment IndicatorsCare and Treatment Indicators Slide 7 PMTCT IndicatorsPMTCT Indicators Slide 51 Indicators for TB Screening in HIV Care Settings Indicators for TB Screening in HIV Care Settings Slide 61 Indicators for HIV Testing in TB PatientsIndicators for HIV Testing in TB Patients Slide 68 Indicators for HIV Testing and CounselingIndicators for HIV Testing and Counseling Slide 74 Indicators for Clinical Laboratories Indicators for Clinical Laboratories Slide 87

S ITE C ENSUS What: Ongoing, real-time inventory of all planned, current, and closed ICAP facilities. Supported activities, funding source(s) and their targets are also captured Purpose: To have one up to date master list of facilities, activities, funding sources, and targets that all ICAP staff can refer to for planning and evaluation

N UMBER OF SELECTED ACTIVITIES AT SUPPORTED FACILITIES, AS OF S EPTEMBER 30, 2011 Number of facilities Source: ICAP Site Census, November 2011 Note: Some facilities offer more than one activity.

Number of facilities N UMBER OF FACILITIES BY COUNTRY, AS OF S EPTEMBER 30, 2011 Source: ICAP Site Census, November 2011

Number of facilities N UMBER OF FACILITIES EVER SUPPORTED BY ICAP AND TRANSITIONED AS OF S EPTEMBER 2011 Source: Source: ICAP Site Census, November 2011 Notes: In transition: A facility may be partially supported by an NGO or MOH but ICAP is still the prime for support and reports directly to Atlanta under MCAP. Completed transition: ICAP is no longer the prime and there is a new mechanism for supporting the site and reporting to USG (e.g., NGO, MOH or another partner).

C ARE AND TREATMENT INDICATORS

P ROGRAM AND F ACILITY C HARACTERISTICS T RACKING S YSTEM (PF A CTS) What: Collects program and facility information on ICAP-supported care and treatment programs annually Purpose: To describe the scope, diversity, and comprehensiveness of ICAP-supported care and treatment programs, and evaluate multi-level factors that influence program performance and patient-level outcomes

Percent of clinics Source: ICAP PFaCTS Round 6, November Note: Clinics for which location and site type are not available are excluded. Urban = officially designated cities with city administration and political bodies; Semi-urban = large and small towns, peri-urban areas, growth points and mining communities; Rural = subsistence and commercial farming areas. HIV CARE AND TREATMENT CLINICS : G EOGRAPHIC LOCATION AND TYPE OF FACILITY (n=790)

Percent of clinics Source: ICAP PFaCTS Round 6, November Note: Clinics for which location and site type are not available are excluded. Urban = officially designated cities with city administration and political bodies; Semi-urban = large and small towns, peri-urban areas, growth points and mining communities; Rural = subsistence and commercial farming areas. G EOGRAPHIC LOCATION OF HIV CARE AND TREATMENT FACILITIES, BY COUNTRY

Percent with services P ROPORTION OF HIV CARE AND TREATMENT CLINICS * OFFERING OTHER HIV- RELATED SERVICES (n=789) Source: ICAP PFaCTS Round 6, November Note: *“Facility” refers to the larger institution, while “clinic” refers to the unit where care and treatment is provided. **PICT is available at one or more points of service in the facility.

P ROPORTION OF CLINICS * OFFERING ≥4 HIV- RELATED SERVICES AT THE SAME FACILITY (n=789) Average =44% Percent of clinics with ≥4 services Source: ICAP PFaCTS Round 6, November Note: “Facility” refers to the larger institution, while “clinic” refers to the unit where care and treatment is provided. **Services include: VCT, PICT, TB treatment, PMTCT, and ART pharmacy.

P ROPORTION OF HIV CARE AND TREATMENT CLINICS OFFERING PATIENT SUPPORT SERVICES (n=789) Percent with service Source: ICAP PFaCTS Round 6, November Notes: Facilities with missing data are excluded. ART adherence counseling: Verbal patient education provided by trained personnel at least every 3 months. Outreach: patients who miss clinic follow-up or medication pick up visits are identified and contacted by facility personnel. Nutritional treatment or support for children/infants: provision of nutritional supplements or weaning foods. Nutritional treatment for adults: provision of nutritional supplements or therapeutic foods, e.g. Plumpy’Nut. Food rations: provision of rations, e.g. snacks or food packets to promote ART adherence or household food security.

Source: ICAP PFaCTS Round 6, November Note: Laboratory services offered: Within the facility: specimen collection and testing done within this facility. At another facility: specimen collection done within this facility and testing conducted at another facility or both specimen collection and testing are conducted at another facility. A VAILABILITY OF LABORATORY ASSAYS AT FACILITIES (n=790) Percent of facilities

P ROPORTION OF ICAP- SUPPORTED FACILITIES WITH ON - SITE ACCESS TO AT LEAST ONE KEY HIV- RELATED LAB ASSAY (n=790) Percent of facilities Source: ICAP PFaCTS Round 6, November Note: Key laboratory assays include: CD4, CD4 percent, HIV-RNA, LFT. PCR laboratory tests are excluded.

M EAN NUMBER OF FULL - TIME HEALTH CARE PROVIDERS AT HIV CARE AND TREATMENT CLINICS (n=782) Mean number of providers Source: ICAP PFaCTS Round 6, November 2011.

M EAN NUMBER OF OUTREACH WORKERS AT ICAP- SUPPORTED HIV CARE AND TREATMENT CLINICS WITH OUTREACH PROGRAMS (n=647*) Mean number of outreach workers Source: ICAP PFaCTS Round 6, November Note: *Only facilities with outreach programs

P ROPORTION OF HIV CARE AND TREATMENT CLINICS OFFERING PATIENT SUPPORT SERVICES OVER TIME (n=431*) Source: ICAP PFaCTS Round 6, November Notes: *Only clinics that submitted all three rounds of data collection are included. ART adherence counseling: Verbal patient education provided by trained personnel at least every 3 months. Outreach: patients who miss clinic follow-up or medication pick up visits are identified and contacted by facility personnel.

Source: ICAP PFaCTS Round 6, November P ROPORTION OF HIV CARE AND TREATMENT CLINICS WHERE NURSES PRESCRIBE ARV S, BY TYPE OF VISIT (n=790) Percent of clinics

C ARE AND TREATMENT QUARTERLY AGGREGATE M&E INDICATORS What: Collects information from ICAP-supported clinics on a quarterly basis. Purpose: To describe quarterly and cumulative progress towards targets and overall achievements. 43 collected indicators include care enrollment, ART initiation and enrollment, regimen information, and ART CD4 cohort information.

HIV CARE AND TREATMENT SERVICES AT FACILITIES, AS OF S EPTEMBER 30, 2011 Source: ICAP URS November Note: Closed facilities includes facilities that have transitioned to MoH, a local NGO, or another implementing partner. Closed facilities also include clinics previously supported through the MTCT+ Initiative.

C ARE AND TREATMENT CLINICS REPORTING AS OF S EPTEMBER 30, 2011 Source: ICAP URS November 2011.

N EW ENROLLMENT IN HIV CARE AND TREATMENT, BY QUARTER Source: ICAP URS November Note: New enrollment includes adults and children. New on treatment include patients who transfer in already on ART. Data are only from clinics currently supported and reporting. The country arrows depict when the country began contributing data. Number of new patients 33,337 initiating ART 55,214 enrolling in care 730 clinics Number of clinics Mozambique, Rwanda, S. Africa, Tanzania Ethiopia Nigeria, Kenya Côte d’Ivoire Swaziland

C UMULATIVE ENROLLMENT IN HIV CARE AND TREATMENT Source: ICAP URS November Notes: Data are only from clinics supported and reporting. The country arrowss depict when the country began contributing data. Number of patients Number of clinics 534,124 on ART 1,083,253 in care 730 clinics Mozambique, Rwanda, S. Africa, Tanzania Ethiopia Nigeria, Kenya Côte d’Ivoire Swaziland

46,757 on ART C UMULATIVE PEDIATRIC ENROLLMENT IN HIV CARE AND TREATMENT Source: ICAP URS November Note: Includes adults and children. Data are only from clinics currently supported and reporting. The country boxes depict when the country began contributing data. Number of patients Number of clinics 92,405 in care 730 clinics Mozambique, Rwanda, S. Africa, Tanzania Ethiopia Nigeria, Kenya Côte d’Ivoire Swaziland

C UMULATIVE ENROLLMENT IN HIV CARE, BY COUNTRY (n= 1,083,253) Mozambique South Africa Ethiopia Kenya Tanzania Rwanda Nigeria Number of patients Swaziland Source: ICAP URS November Notes: Data is only from care and treatment clinics supported by ICAP and reporting. Côte d’Ivoire

Mozambique South Africa Ethiopia Kenya Tanzania Rwanda Nigeria Swaziland Number of patients C UMULATIVE ENROLLMENT ON ART, BY COUNTRY (n=534,124) Côte d’Ivoire Source: ICAP URS November Notes: Data are only from clinics supported and reporting.

C UMULATIVE PERSON - YEARS ON ART, AS OF S EPTEMBER 30, 2011 Cumulative person-years on ART Source: ICAP URS November 2011 Notes: Cumulative person years on ART is calculated as the cumulative number of patients on ART by time they have been on ART. Those who are known to have died, transferred, or lost to follow-up stop contributing time when their new status is reported.

ART patients currently retained in HIV care* C UMULATIVE PATIENTS INITIATED ON ART AND THEIR CURRENT STATUS, AS OF S EPTEMBER 30, 2011 (n= 534,124) Number of patients Source: ICAP URS November 2011 Notes: Data are only from clinics currently supported and reporting. Data include patients who have temporarily stopped ART for clinical reasons, but are continuing in HIV care. Cumulative ever initiating ART Reported dead Lost to follow-up

Total care enrollment (n= 1,083,253 ) Total ART enrollment (n= 534,124 ) C UMULATIVE ENROLLMENT IN HIV CARE AND TREATMENT PROGRAMS, BY ART STATUS, AGE, AND SEX Men 15+ Women 15+ Children <15 Men 15+ Women 15+ Source: ICAP URS November 2011 Notes: Data is only from care and treatment clinics supported and reporting. 61% 30% 9% 59% 32% 9%

C UMULATIVE ART INITIATION BY SEX AT ICAP- SUPPORTED FACILITIES IN 10 SUB -S AHARAN A FRICAN COUNTRIES Women (n= 340,831) Men (n= 193,293) Source: ICAP URS November 2011 Notes: Data is only from care and treatment clinics supported by ICAP and reporting. Number of patients

Source: URS November 2011 Notes: Data are only from clinics currently supported and reporting. P ROPORTION OF ALL PATIENTS EVER ENROLLED IN HIV CARE WHO EVER INITIATED ART, AS OF S EPTEMBER 30, 2011 Percent of patients

P ROPORTION OF ALL PATIENTS EVER ENROLLED IN HIV CARE, BY ART STATUS, AGE AND SEX, AS OF S EPTEMBER 30, 2011 Percent of patients Source: ICAP URS November 2011 Notes: Data are only from clinics currently supported and reporting.

C UMULATIVE ENROLLMENT IN CARE, BY COUNTRY, AGE, AND SEX, AS OF S EPTEMBER 30, 2011 Percent of patients Source: ICAP URS November 2011 Note: Data are only from clinics currently supported and reporting.

Percent of patients C UMULATIVE ART INITIATION, BY COUNTRY, AGE, AND SEX, AS OF S EPTEMBER 30, 2011 Source: ICAP URS November 2011 Note: Data are only from clinics currently supported and reporting.

P REGNANT WOMEN AS A PROPORTION OF ALL WOMEN INITIATING ART Source: ICAP URS November 2011 By Country, July-September 2011 Over Time Percent of women

N EW ART ENROLLMENT OVER THE LAST 8 QUARTERS ( INCLUDING NEW FACILITIES ) Source: ICAP URS November 2011 Notes: Data from care and treatment clinics currently supported and reporting. Many countries have added clinics each quarter which has affected the enrollment. Number of patients

N EW ART ENROLLMENT OVER THE LAST 4 QUARTERS ( CONSTANT NUMBER OF FACILITIES ) Source: ICAP URS November 2011 Notes: Data from care and treatment clinics currently supported and reporting all quarters. Number of patients

P ROPORTION OF NEW ART PATIENTS, BY AGE AND SEX, J ULY -S EPTEMBER 2011 Source: ICAP URS November 2011

Percent of pediatric patients C UMULATIVE PEDIATRIC HIV CARE ENROLLMENT, AS OF S EPTEMBER 30, 2011 Source: ICAP URS November 2011

C UMULATIVE PEDIATRIC ART ENROLLMENT, AS OF S EPTEMBER Percent pediatric patients on ART Source: ICAP URS November 2011

ART INITIATION AMONG PATIENTS ELIGIBLE FOR ART IN ICAP- SUPPORTED PROGRAMS, J ULY -S EPTEMBER 2011 Percent patients eligible for ART Source: ICAP URS November 2011 Note: Eligible, but not started: Number in HIV care during the quarter and eligible for ART but NOT started ART by the end of the quarter. Eligible, started: All those who were eligible and started on ART during the reporting quarter.

R EGIMENS USED BY CURRENT ART PATIENTS, J ULY -S EPTEMBER 2011 Source: ICAP URS November 2011 Notes: Data are only from clinics currently supported and reporting.

R EGIMENS USED BY CURRENT ADULT ART PATIENTS BY COUNTRY, J ULY -S EPTEMBER 2011 Source: ICAP URS November 2011 Notes: * In South Africa, D4T-3TC-LPV/r, ZDV-ddl-LPV/r, and ABC-ddl-LPV/r are prescribed as a first-line regimen for pediatric patients. ^ Nigeria only reports regimen information for newly enrolled patients on ART. Data are only from clinics currently supported and reporting.

R EGIMENS USED BY CURRENT PEDIATRIC ART PATIENTS BY COUNTRY, J ULY -S EPTEMBER 2011 Source: ICAP URS November 2011 Notes: ^ Nigeria only reports regimen information for newly enrolled patients on ART. Data are only from clinics currently supported and reporting.

P ROPORTION OF PATIENTS WITH CD4 COUNT AT BASELINE, 6, AND 12 MONTHS AFTER ART INITIATION ( SUBSET OF ART PATIENTS *) Percent of patients Source: ICAP URS November 2011 Notes: *Data only included for patients who were followed for 12 months. Data are only from clinics currently supported and reporting.

M EDIAN CD4 COUNT AT BASELINE *, 6, AND 12 MONTHS AFTER ART INITIATION ( SUBSET OF ART PATIENTS **) CD4 Cell Count (cells/ul) Source: ICAP URS November 2011 Notes: Average of median CD4 counts at baseline and 6 and 12 months follow up are presented. * Baseline data is average of matched 6 and 12 month cohort data at baseline. ** Data only included for patients who were followed for 12 months. Data are only from clinics currently supported and reporting.

C HANGE IN MEDIAN CD4 COUNT AFTER 6 AND 12 MONTHS OF ART ( SUBSET OF ART PATIENTS *) Change in median CD4 count (cells/µL) Source: ICAP URS November 2011 Notes: Change in average of median CD4 counts at baseline and 6 and12 months follow up are presented. *Data only included for patients who were followed for 12 months. Data are only from clinics currently supported and reporting.

7% per year on ART S TATUS OF ART PATIENTS, AS OF S EPTEMBER 30, 2011 (n= 541,983).14% per year on ART Lost to follow-up Reported dead Stopped ART Source: ICAP URS November 2011 Notes: *Includes patients who transferred out while on ART. Data are only from clinics currently supported and reporting. Rates 3.5% per year on ART

R EASONS FOR ART DISCONTINUATION IN ICAP- SUPPORTED HIV CLINICS, AS OF S EPTEMBER 30, 2011 Percent of discontinuing patients Source: ICAP URS November 2011 Notes: Excludes patients who transferred out while on ART.

PMTCT I NDICATORS

PMTCT QUARTERLY AGGREGATE M&E INDICATORS What: Collects information from ICAP-supported facilities on a quarterly basis Purpose: To describe quarterly and cumulative progress towards targets and overall achievements through 32 indicators covering the counseling, testing, HIV results, and ultimately, the treatment of HIV positive pregnant women and their exposed infants.

PMTCT FACILITIES REPORTING AS OF S EPTEMBER 30, 2011 Source: ICAP URS November 2011

N UMBER OF PREGNANT WOMEN ATTENDING ANC AND RECEIVING HIV TESTING, J UNE 2007 – S EPTEMBER 2011 Source: ICAP URS November The country arrows depict when the country started contributing data. 1,888 clinics 132,171 HIV tests 236,874 ANC visits Number of women Number of clinics S. Africa Côte d’Ivoire Mozambique, Rwanda, Ethiopia, Nigeria, Tanzania Kenya

Percent of women T YPE OF ART REGIMEN FOR PMTCT, BY COUNTRY, J ULY -S EPTEMBER 2011 Source: ICAP URS November Notes: Multi-drug regimens include AZT/sd-NVP, AZT/3TC tail postpartum, HAART at 34 weeks. 20% HAART target

n= 4,027 n= 3,684 n= 4,075 n= 5,133 n= 6,018 n= 5,778 n= 7,582 n= 7,931 n= 8,327 n= 7,990 n= 10,147 n= 8,574 n= 8,994 T YPE OF ART REGIMEN FOR PMTCT, BY QUARTER Percent of women Source: ICAP URS November 2011 Notes: Multi-drug regimens include AZT/sd-NVP, AZT/3TC tail postpartum, HAART at 34 weeks. 20% HAART target

Percent P ROPORTION OF HIV+ WOMEN WITH DOCUMENTED CD4 TEST RESULTS IN CLINICS OFFERING CD4 TESTING 90% target for sites reporting CD4 Source: ICAP URS November 2011

P ROPORTION OF HIV+ WOMEN AND INFANTS RECEIVING PMTCT PROPHYLAXIS AT ANC AND MATERNITY Source: ICAP URS November 2011 Note: Proportions for Kenya are based on women who tested positive for HIV in ANC only. Percent

ART ELIGIBILITY AND INITIATION OF ART AMONG HIV+ PREGNANT WOMEN Number of women Source: ICAP URS November 2011 Notes: Data is not available for all indicators in all countries.

HIV E XPOSED I NFANTS, J ULY -S EPTEMBER 2011 Source: ICAP URS November 2011 Notes: Data is not available for all indicators in all countries. HIV exposed infants includes women who tested positive in ANC and those who tested positive in maternity during the quarter.

Indicators for TB Screening in HIV Care Settings What: Collects information from ICAP-supported facilities on a quarterly basis Purpose: To describe quarterly and cumulative progress towards targets and overall achievements, through 12 collected indicators.

TB S CREENING IN HIV C ARE S ETTINGS AS OF S EPTEMBER 30, 2011 Source: ICAP URS November 2011

P ROPORTION OF NEW HIV CARE PATIENTS SCREENED FOR TB, J ULY -S EPTEMBER 2011 Percent of patients 90% target Source: ICAP URS November 2011 Notes: Data are only from clinics currently supported and reporting. New HIV care patients excludes patients who knew their TB status. New HIV care patients

P ROPORTION OF NEW HIV CARE PATIENTS SCREENED FOR TB, BY QUARTER Percent of patients Source: ICAP URS November 2011 Note: Côte d’Ivoire began reporting in April-June 2008 quarter and South Africa began in July-September 2008 quarter. Data are only from clinics currently supported and reporting. As of March 2010, new HIV care patients excludes patients who knew their TB status at enrollment. n=32,184 n=29,286 n=33,184 n=33,049 n=34,069 n=34,783 n=38,722 n=36,180 n=35,229 n=39,762 n=48,983 n=43,339 n=41,084 Number of clinics New HIV care patients with unknown status

P ROPORTION OF ALL HIV PATIENTS SCREENED FOR TB WHO SCREENED POSITIVE, J ULY -S EPTEMBER 2011 Percent of patients Source: ICAP URS November 2011 Patients Screened

Patients screened positive P ROPORTION OF ALL NEW HIV PATIENTS WITH A POSITIVE TB SCREEN WHO INITIATED TB TREATMENT, J ULY -S EPTEMBER 2011 Percent of patients Source: ICAP URS November 2011

P ROPORTION OF ALL NEW HIV CARE PATIENTS WHO INITIATED TB TREATMENT, J ULY -S EPTEMBER 2011 Source: ICAP URS November 2011 Note: Although Ethiopia does not report other TB indicators, they do report diagnosis data and are therefore included in this graph. Data are only from clinics currently supported and reporting. Percent of patients New HIV care patients

I NDICATORS FOR HIV T ESTING IN TB P ATIENTS What: Collects information from ICAP-supported facilities on a quarterly basis Purpose: To describe quarterly and cumulative progress towards targets and overall achievements through 16 collected indicators.

HIV TESTING IN TB CLINICS, AS OF S EPTEMBER 30, 2011 Source: ICAP URS November 2011

P ROPORTION OF NEW TB PATIENTS WITH UNKNOWN HIV STATUS TESTED FOR HIV, J ULY -S EPTEMBER 2011 Percent of patients New TB patients w/ unknown HIV status Source: ICAP URS November 2011

P ROPORTION OF NEW TB PATIENTS WITH UNKNOWN HIV STATUS AT ICAP- SUPPORTED TB CLINICS TESTED FOR HIV OVER TIME Percent of patients n=7,063 n=9,109 n=10,506 n=10,328 n=11,303 n=7,243 n=10,624 n=13,920 n=11,591 TB patients with unknown HIV status Source: ICAP URS November 2011.

P ROPORTION OF TB PATIENTS WHO TESTED HIV POSITIVE, BY COUNTRY, J ULY -S EPTEMBER 2011 Percent of patients New TB patients tested for HIV Source: ICAP URS November Note: In Nigeria, Ethiopia, Mozambique, Côte d’Ivoire, and Rwanda, the bar represents the proportion of new TB patients with an unknown HIV status who were HIV tested at the TB clinic upon enrollment. In Kenya and South Africa, the bar represents those new TB patients who were HIV tested at any clinic. Tested at any clinicTested at TB clinic

P ROPORTION OF HIV(+) TB PATIENTS ENROLLING IN HIV CARE, J ULY -S EPTEMBER 2011 Percent of patients New TB patients testing positive for HIV Source: ICAP URS November Note: In Nigeria, Ethiopia, Mozambique, Côte d’Ivoire, Rwanda, the bar represents the proportion of new TB patients with an unknown HIV status who were HIV tested at the TB clinic upon enrollment. In Kenya, South Africa, and DR Congo, the bar represents those new TB patients who were HIV tested at any clinic. Tested at any clinicTested at TB clinic

Indicators for HIV Testing and Counseling What: Collects information from ICAP-supported facilities on a quarterly basis Purpose: To describe quarterly and cumulative progress towards targets and overall achievements through 9 indicators.

C OUNSELING AND TESTING, AS OF S EPTEMBER Source: ICAP URS November 2011

N UMBER OF FACILITIES REPORTING COUNSELING AND TESTING, BY COUNTRY OVER TIME Source: ICAP URS November 2011 Note: Counseling and testing data was not reported until December 2009 Kenya Nigeria South Africa Tanzania Mozambique Ethiopia Number of facilities Rwanda DR Congo Côte d’I’voire

HIV TESTING AND COUNSELING, CUMULATIVE EXPERIENCE, AS OF S EPTEMBER 30, 2011 Source: ICAP URS November 2011 Notes: Data are not available for all indicators in all points of service. Number of patients

N UMBER OF CLIENTS COUNSELED AND TESTED AND RECEIVED RESULTS, OVER FIVE MOST RECENT QUARTERS Source: ICAP URS November 2011 Number of patients

N UMBER OF CLIENTS COUNSELED AND TESTED AND RECEIVED RESULTS, BY SEX, OVER FIVE MOST RECENT QUARTERS Source: ICAP URS November 2011 Number of patients Sep-10 Dec-10 Mar-11 Jul-11 Sep-11

N UMBER OF CLIENTS COUNSELED AND TESTED, RECEIVED RESULTS, AND ENROLLED IN CARE AND TREATMENT, BY AGE, OVER THREE MOST RECENT QUARTERS Source: ICAP URS November 2011 Notes: Sites which are not able to specify patient age are excluded. Number of patients Mar-11 Jun-11 Sep-11

Number of patients Source: ICAP URS November 2011 Note: *Most data from VCT clinics comes from Ethiopia, which may decrease the overall % positive found in VCT clinics; **Other includes: laboratory, family planning, well baby clinic, casualty/trauma, palliative care/hospice, customer care, cervical cancer screening, STI clinic, HIV care / ART (family testing), TB clinic, blood donation center, PITC (all), and other. N UMBER OF ADULT AND PEDIATRIC PATIENTS COUNSELED AND TESTED, BY POINT OF SERVICE, J ULY -S EPTEMBER 2011

Source: ICAP URS November 2011 Note: * Most data from VCT clinics comes from Ethiopia, which may decrease the overall prevalence found in VCT clinics; ** Other includes: laboratory, family planning, well baby clinic, casualty/trauma, palliative care/hospice, customer care, cervical cancer screening, STI clinic, HIV care / ART (family testing), TB clinic, blood donation center, PITC (all), and other. N UMBER OF ADULT PATIENTS COUNSELED AND TESTED, BY POINT OF SERVICE, J ULY -S EPTEMBER 2011 Number of patients

Source: ICAP URS November 2011 Note: *Most data from VCT clinics comes from Ethiopia, which may decrease the overall prevalence found in VCT clinics; **Other includes: laboratory, family planning, well baby clinic, casualty/trauma, palliative care/hospice, customer care, cervical cancer screening, STI clinic, HIV care / ART (family testing), TB clinic, blood donation center, PITC (all), and other. N UMBER OF PEDIATRIC PATIENTS COUNSELED AND TESTED, BY POINT OF SERVICE, J ULY -S EPTEMBER 2011 Number of patients

Source: ICAP URS November 2011 Notes: Excludes pregnant women tested as part of PMTCT. N UMBER OF PATIENTS RECEIVING PRE - TEST COUNSELING AND TESTING, BY COUNTRY, J ULY -S EPTEMBER 2011 Number of patientsNumber of facilities

Source: ICAP URS November 2011 P ERCENT OF PATIENTS WHO WERE HIV+, BY COUNTRY, J ULY -S EPTEMBER 2011 Percent of patients

Source: ICAP URS November Note: Kenya, Rwanda, and Nigeria do not currently report enrollment or referral to HIV care data. P ERCENT OF POSITIVE PATIENTS ENROLLED INTO CARE AND TREATMENT, BY COUNTRY, J ULY -S EPTEMBER 2011 Number of patients

Indicators for Clinical Laboratories What: Collects information from ICAP-supported facilities on a quarterly basis Purpose: To describe quarterly and cumulative progress towards targets and overall achievements through 2 indicators.

P ROPORTION OF CARE AND TREATMENT FACILITIES WITH CLINICAL LABORATORIES, J ULY -S EPTEMBER 2011 Percent of facilities with clinical laboratories Source: ICAP Site Census June Number of care and treatment facilities

Number of tests HIV- RELATED TESTS CONDUCTED BY COUNTRY, J ULY -S EPTEMBER 2011 Source: ICAP URS November 2011 Note: Nigeria did not report PCR, viral load, or EIA. Ethiopia did not report any lab tests, but they do support laboratory services Number of facilities

For more information, please see: ICAP URS ICAP Data Dissemination Page PFACTS Country Reports